3 rd Announcement - 2011 International Conference on Diabetes ...

Scientific program
Satu<strong>rd</strong>ay 12 NOV. (15:20~17:20)
Chairs : Moon-Gi Choi, Michael Hirst
S13 Diabetes prevention program in Asia
S13-1 Introduction to diabetes in Asia and Ansung-Ansan community cohort epidemiologic
study
Nam Han Cho (Ajou University, Korea)
S13-2 Long term effects of lifestyle intervention in different ethnic group
Guangwei Li (China-Japan Friendship Hospital, China)
S13-3 Japan diabetes prevention program (JDPP) and Japan diabetes outcome
intervention trial-1 (J-DOIT1)
Panel 1
Panel 2
Naoki Sakane (National Hospital Organization Kyoto Medical Center, Japan)
Byoung Joon Kim (Konyang University, Korea)
Eun Jung Rhee (Sungkyunkwan University, Korea)
Satu<strong>rd</strong>ay 12 NOV. (15:20~17:20)
Chairs : Tai Hee Lee, Ki Up Lee
S14 Novel targets in steatosis and steatohepatitis
S14-1 Myriocin prevents non-alcoholic steatohepatitis in mice fed methionine-cholinedeficient
diet
Ki Up Lee (University of Ulsan, Korea)
S14-2 Selenoprotein P as a hepatokine that causes insulin resistance
Toshinari Takamura (Kanazawa University, Japan)
S14-3 Blockade of mineralocorticoid receptor ameliorates glucose metabolism and
steatohepatitis in a novel mice model of non-alcoholic steatohepatitis
Tsutomu Wada (University of Toyama, Japan)
S14-4 Protection against hepatic steatosis and systemic insulin resistance by conditional
knockdown of p70 S6 kinase in liver
Eun Ju Bae (Woosuk University, Korea)
Satu<strong>rd</strong>ay 12 NOV. (15:20~17:20)
Chairs : Hyung Joon Yoo, Duk-Kyu Kim
S15 Microvascular aspect of diabetic complications
S15-1 Heart in diabetes; a microvascular disease (diabetic ca<strong>rd</strong>iomyopathy)
Woo Jin Park (Gwangju Institute of Science and Technology, Korea)
S15-2 Management of diabetic foot problems in the western pacific region
Shigeo Kono (Kyoto Medical Center, Japan)
S15-3 Diabetic nephropathy; new opportunities and new therapeutics
Merlin C Thomas ( Baker IDI Heart and Diabetes Institute, Australia)
S15-4 HbA1c variability as a risk of microvascular complication in diabetes
Hirohito Sone (University of Tsukuba Institute of Clinical Medicine, Japan)